Shanghai Aladdin Biochemical Technology Co., Ltd.

Shanghai Aladdin Biochemical Technology Co., Ltd. saw a notable increase in stock performance today, contrasting with the broader market. Despite recent challenges, including a decline over the past week and month, the company has shown resilience over the past year, outperforming the China Shanghai Composite index.

Shanghai Aladdin Biochemical Technology Co., Ltd. faced notable stock volatility, hitting an intraday low and experiencing significant weekly and monthly declines. Despite a year-to-date gain, the company reported a substantial net profit drop and low operational efficiency, with a high price-to-book ratio and modest dividend yield.

Shanghai Aladdin Biochemical Technology Co., Ltd. faced notable volatility on July 17, 2026, with a significant stock decline. Over the past week, the stock has dropped 25.04%, but it has shown a strong annual return of 39.68%. The company has a market capitalization of CNY 5,631 million.

Shanghai Aladdin Biochemical Technology Co., Ltd. saw a notable stock decline today, contrasting with the broader market's performance. Despite recent downturns, the company has shown strong year-to-date growth and resilience over the past year, although financial metrics raise some concerns regarding profitability and valuation.

Shanghai Aladdin Biochemical Technology Co., Ltd. saw its stock price decline significantly today, contrasting with the broader market's performance. Despite a strong yearly return, the company faces financial pressures, including a drop in profits and concerns over operational efficiency, while maintaining a low debt-to-equity ratio and modest dividend yield.

Shanghai Aladdin Biochemical Technology Co., Ltd. has seen a significant rise in its stock performance, contrasting with the broader market. Over the past month, the stock has increased substantially, despite a notable decline in net profit in recent half-year results. The company operates within the pharmaceuticals and biotechnology sector.

Shanghai Aladdin Biochemical Technology Co., Ltd. has seen notable stock activity, with significant gains over the past week and year-to-date. Despite recent performance improvements, the company reported a substantial decline in net profit in its latest half-year results, facing challenges in maintaining growth.

Shanghai Aladdin Biochemical Technology Co., Ltd. saw its stock price decline significantly today, contrasting with the broader market. The company reported a 39.53% drop in net profit in its latest half-year results, despite a substantial increase in interest. Its financial metrics indicate elevated valuations amid ongoing market challenges.

Shanghai Aladdin Biochemical Technology Co., Ltd. faced a notable stock decline today, with a significant drop during trading. Despite recent challenges, the company has shown strong year-to-date performance and maintains a low debt-to-equity ratio, highlighting its conservative financial strategy amidst fluctuating market conditions.

Shanghai Aladdin Biochemical Technology Co., Ltd. saw a notable stock decline today, contrasting with the broader market. Despite recent challenges, the company has shown strong year-to-date performance and positive monthly returns. Key financial metrics include a market capitalization of CNY 4,399 million and a price-to-earnings ratio of 42.00.

Shanghai Aladdin Biochemical Technology Co., Ltd. saw a significant stock decline today, contrasting with the broader market's performance. Despite recent challenges, including a drop in net profit and a low return on capital, the company has shown strong yearly gains, highlighting its midcap status in the pharmaceuticals sector.

Shanghai Aladdin Biochemical Technology Co., Ltd. saw a significant stock decline today, contrasting with the minor decrease in the China Shanghai Composite. Despite recent challenges, including a notable profit drop, the company has shown strong year-to-date performance and maintains a premium valuation with a dividend yield appealing to income-focused investors.

Shanghai Aladdin Biochemical Technology Co., Ltd. has seen a notable rise in stock performance, with significant gains over various timeframes. Despite challenges such as declining net profit and a high price-to-earnings ratio, the company maintains a strong market presence in the Pharmaceuticals & Biotechnology sector.

Shanghai Aladdin Biochemical Technology Co., Ltd. saw a notable stock decline today, contrasting with the broader market. Despite a yearly return of 35.37%, the company reported a significant drop in net profit and a low return on capital employed, raising concerns about its financial health.

Shanghai Aladdin Biochemical Technology Co., Ltd. has seen notable stock performance, with significant gains over the past week and month, contrasting with a decline in the broader market. However, the company faces profitability challenges, reporting a substantial net profit decline in its latest half-year results.